This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nagai, T. Articles by Komuro, I. Search for Related Content PubMed PubMed Citation Articles by Nagai, T. Articles by Komuro, I. Related Collections Related Article

(Circulation Research. 2005;97:615.)
© 2005 American Heart Association, Inc.

Editorials

Promotion of Cardiac Regeneration by Cardiac Stem Cells

Toshio Nagai, Ichiro Shiojima, Katsuhisa Matsuura, Issei Komuro

From the Department of Cardiovascular Science and Medicine (T.N., I.S., K.M., I.K.), Chiba University Graduate School of Medicine, Chiba; and the Department of Cardiology (K.M.), Tokyo Women’s Medical University, Tokyo, Japan.

Correspondence to Issei Komuro, MD, PhD, Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. E-mail komuro-tky@umin.ac.jp

See related article, pages 663–673

Key Words: cardiac stem cell • cardiomyocytes • regeneration • growth factor • myocardial infarction

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Research on myocardial regeneration is an exciting and promising area, which challenges the dogma that the heart is a nonregenerating organ. Recently, several methods of stem cell therapy have been developed. One method is to transplant cells into the infarcted area of the myocardium. Currently, clinical trials of autologous skeletal myoblast transplantation into the failed heart are underway and have been reported to improve the cardiac function.¹ However, the mechanism of its efficacy is unknown, and there are some questions about the safety because myoblasts do not transdifferentiate into cardiomyocytes and may induce lethal arrhythmia.¹ In this point, embryonic stem (ES) cells that can differentiate into cardiomyocytes are thought to be more promising.² For patients experiencing extensive myocardial infarction or dilated cardiomyopathy, however, the effectiveness of cell transplantation is questionable. Bone marrow-derived cells have been reported to transdifferentiate into various types of cells in situ. Indeed, bone marrow-derived stem cells were reported to prevent left ventricular remodeling after myocardial infarction and improve cardiac function by their differentiation into cardiomyocytes.³ However, recent accumulating evidence has indicated that very few bone marrow cells, if any, transdifferentiate into cardiomyocytes.^4–6 Cytokine therapy using G-CSF strongly prevents ventricular remodeling after myocardial infarction by antiapoptotic and angiogenic effects, but not by recruitment of bone marrow cells.⁷

Over the past few years, adult hearts have been reported to contain the cardiac stem/progenitor cells such as c-kit+,⁸ Sca-1+,^9,10 isl-1+,¹¹ and side population cells.¹² Because these cells have the ability to proliferate and differentiate into cardiomyocytes in vitro and . . . [Full Text of this Article]

Related Article:

Cardiac Stem Cells Possess Growth Factor-Receptor Systems That After Activation Regenerate the Infarcted Myocardium, Improving Ventricular Function and Long-Term Survival

Konrad Urbanek, Marcello Rota, Stefano Cascapera, Claudia Bearzi, Angelo Nascimbene, Antonella De Angelis, Toru Hosoda, Stefano Chimenti, Mathue Baker, Federica Limana, Daria Nurzynska, Daniele Torella, Francesco Rotatori, Raffaella Rastaldo, Ezio Musso, Federico Quaini, Annarosa Leri, Jan Kajstura, and Piero Anversa
Circ. Res. 2005 97: 663-673. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

				J. Chen and M. S. Goligorsky Premature senescence of endothelial cells: Methusaleh's dilemma Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1729 - H1739. [Abstract] [Full Text] [PDF]